𝔖 Bobbio Scriptorium
✦   LIBER   ✦

The cholinergic pathology in Alzheimer's disease – discrepancies between clinical experience and pathophysiological findings

✍ Scribed by L. Frölich

Publisher
Springer
Year
2002
Tongue
English
Weight
76 KB
Volume
109
Category
Article
ISSN
1435-1463

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Clinical trials with the cholinergic dru
Clinical trials with the cholinergic drug RS 86 in Alzheimer's disease (AD) and senile dementia of the Alzheimer type (SDAT)
✍ Albert Wettstein; René Spiegel 📂 Article 📅 1984 🏛 Springer 🌐 English ⚖ 216 KB

The muscarinic agonist RS 86 was administered to patients with Alzheimer's disease (AD) and senile dementia of the Alzheimer type (SDAT) in a series of controlled clinical trials. Daily doses were up to 3.0 mg orally for a maximum duration of 18 weeks. RS 86 produced typical peripheral cholinergic e

Role of amyloid β peptides in the regula
Role of amyloid β peptides in the regulation of central cholinergic function and its relevance to Alzheimer's disease pathology
✍ S. Kar 📂 Article 📅 2002 🏛 John Wiley and Sons 🌐 English ⚖ 156 KB 👁 1 views

## Abstract The neuropathological features associated with Alzheimer's disease (AD) brain include the presence of extracellular neuritic plaques composed of amyloid β protein (Aβ), intracellular neurofibrillary tangles containing hyperphosphorylated tau protein, and the loss of basal forebrain chol

The Use of Clinical Experience to Stage
The Use of Clinical Experience to Stage the Severity of Functional Impairments in Alzheimer's Disease
✍ SANFORD I. FINKEL; MANFRED BERGENER; FRANZ W. HULLA; MARK STEMMLER; JOHN E. OVER 📂 Article 📅 1996 🏛 John Wiley and Sons 🌐 English ⚖ 906 KB

Experienced clinicians from Germany and the United States rated the stage of Alzheimer's disease at which each of 44 manifestations of cognitive, bebavioural, or functional impairment is considered most clinically relevant. The resulting data were subjected to three methods of metric scale analysis

No association between the intronic pres
No association between the intronic presenilin-1 polymorphism and Alzheimer's disease in clinic and population-based samples
✍ Cai, Xingang; Stanton, Judith; Fallin, Dani; Hoyne, Jonathan; Duara, Ranjan; Gol 📂 Article 📅 1997 🏛 John Wiley and Sons 🌐 English ⚖ 64 KB 👁 3 views

Mutations in the Presenilin 1 (PS1) gene on chromosome 14 cause most early-onset familial Alzheimer's disease (AD). An intronic polymorphism in the PS1 gene was recently identified and reported to be associated with late-onset AD [Wragg et al., Lancet 347: 509-512, 1996]. The authors found an excess